| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Exelixis, Inc. (EXEL) has 10 insiders with recent SEC Form 4 filings, including 0 buys and 15 sells. EXEL is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.96M | $101.19M | - | |
| Dir | 1.55M | $79.99M | - | |
| Dir | 1.19M | $61.25M | - | |
| CFO | 1.12M | $57.54M | - | |
| VP | 594.7K | $30.63M | -43,451 |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 11, 2020 | Marchesi Vincent T | Director | Sale+OE | 30,000 | $26.30 | $789,000.00 | -26.7% | |
| May 11, 2020 | Hessekiel Jeffrey54 | EVP And General Counsel | Sale+OE | 93,006 | $26.33 | $2,448,882.54 | -11.5% | |
| May 8, 2020 | Haley Patrick J.56 | EVP, Commercial | Sale+OE | 21,375 | $25.87 | $552,971.25 | -15.3% | |
| May 8, 2020 | Papadopoulos Stelios53 | Director | Sale+OE | 45,000 | $25.84 | $1,162,800.00 | -4.1% | |
| May 8, 2020 | Senner Christopher J. | EVP And CFO | Sale+OE | 100,000 | $25.81 | $2,580,785.83 | -29.3% | |
| May 7, 2020 | Lamb Peter63 | EVP, Scientific Strategy &CSO | Sale+OE | 50,000 | $25.54 | $1,277,000.00 | -28.3% | |
| May 7, 2020 | Poste George | Director | Sale+OE | 30,000 | $25.61 | $768,300.00 | -21.0% | |
| May 7, 2020 | Feldbaum Carl B47 | Director | Sale+OE | 31,546 | $25.02 | $789,280.92 | -78.7% | |
| Apr 24, 2020 | Scangos George A77 | Director | Sell | 115,000 | $26.02 | $2,992,235.00 | -4.8% | |
| Apr 23, 2020 | Haley Patrick J.56 | EVP, Commercial | Sale+OE | 5,000 | $26.00 | $130,000.00 | -4.1% |